SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-007974
Filing Date
2019-08-12
Accepted
2019-08-12 16:06:32
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nxtc-20190630x10q.htm 10-Q 1770356
2 EX-31.1 nxtc-20190630ex3118c991b.htm EX-31.1 13475
3 EX-31.L2 nxtc-20190630ex31l28c84a.htm EX-31.L2 12393
4 EX-32.1 nxtc-20190630ex3213dc75a.htm EX-32.1 13674
  Complete submission text file 0001558370-19-007974.txt   4903680

Data Files

Seq Description Document Type Size
5 EX-101.INS nxtc-20190630.xml EX-101.INS 813741
6 EX-101.SCH nxtc-20190630.xsd EX-101.SCH 35119
7 EX-101.CAL nxtc-20190630_cal.xml EX-101.CAL 37881
8 EX-101.DEF nxtc-20190630_def.xml EX-101.DEF 113377
9 EX-101.LAB nxtc-20190630_lab.xml EX-101.LAB 321685
10 EX-101.PRE nxtc-20190630_pre.xml EX-101.PRE 226050
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38905 | Film No.: 191016551
SIC: 2834 Pharmaceutical Preparations